Medical Disclaimer
Effective date: 1 January 2026ASCLEPIUS is designed exclusively as a clinical management and decision support platform for registered, licensed healthcare professionals. It is not intended for use by the general public for self-diagnosis or self-treatment.
All clinical information, AI-generated outputs, drug information, dosage references, ICD-10 codes, clinical guidelines, and other content within this platform are provided to assist qualified practitioners — they do not constitute medical advice to patients and must never be used as such.
Artificial Intelligence — Specific Limitations
AI-powered features in ASCLEPIUS (including differential diagnosis, clinical notes, prescriptions, SBAR handovers, AI prioritisation, and all other AI outputs) are subject to the following important limitations:
- AI can be wrong. AI outputs may contain errors, omissions, hallucinations, or outdated information. Every AI output must be critically evaluated by the treating practitioner.
- AI does not examine patients. AI analysis is based only on the data entered — it cannot replicate a physical examination, clinical intuition, or the full context of a patient encounter.
- Practitioner accountability is non-delegable. The treating health practitioner retains full legal and ethical accountability for all clinical decisions, regardless of any AI suggestion.
- These features comply with HPCSA Booklet 20 (Ethical Guidelines on the Use of Artificial Intelligence in Healthcare, September 2025).
Medication & Dosage Information
Drug information, dosage references, interaction alerts, and prescribing guidance provided within ASCLEPIUS are for practitioner reference only. Always:
- Verify against the current South African Medicines Formulary (SAMF) or equivalent official reference for your country.
- Consider individual patient factors (weight, renal/hepatic function, allergies, comorbidities, pregnancy).
- Check for the most current product information and regulatory updates.
ASCLEPIUS accepts no liability for adverse drug events, incorrect dosing, or harm arising from prescribing decisions.
International Use
ASCLEPIUS supports practitioners across 46 countries with localised billing codes (BHF, CPT, MBS, NHS, EBM, CCAM, and others), drug formularies, and clinical guidelines. However:
- Clinical guidelines and billing rules vary by country and change over time.
- Practitioners must verify compliance with their own national regulatory requirements.
- ASCLEPIUS makes no warranty that content is current or applicable in every jurisdiction.
No Liability for Clinical Outcomes
To the fullest extent permitted by law, ASCLEPIUS, its owners, developers, and affiliated parties accept no liability for any patient harm, adverse clinical outcome, misdiagnosis, incorrect treatment, billing error, data loss, or any other loss arising directly or indirectly from use of this platform or reliance on any information, AI output, or clinical tool within it. Use of ASCLEPIUS constitutes acceptance of this limitation.
- Helping registered practitioners document, organise, and manage clinical encounters efficiently.
- Providing AI-assisted clinical decision support that practitioners can critically evaluate.
- Streamlining billing, ward management, referrals, and communication between healthcare teams.
- Supporting best-practice clinical documentation in compliance with HPCSA and international standards.
